BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 7738659)

  • 1. Technetium-99m-sestamibi/thallium-201 mismatch of thyroid and parathyroid adenoma in chronic renal failure.
    Pijpers R; van Loon BJ; Roos JC; Hoekstra OS
    J Nucl Med; 1995 May; 36(5):826-8. PubMed ID: 7738659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 201Tl-99mTc subtraction scintigraphy in secondary hyperparathyroidism of chronic renal failure.
    Moolenaar W; Heslinga JM; Arndt JW; vd Velde CJ; Pauwels EK; Valentijn RM
    Nephrol Dial Transplant; 1988; 3(2):166-8. PubMed ID: 2845303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
    Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
    Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic imaging using 201Tl and 99mTc-pertechnetate in hyperparathyroidism].
    Gimlette TM; Brownless SM
    Med Radiol (Mosk); 1989 May; 34(5):32-44. PubMed ID: 2542714
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism.
    Hindié E; Urenã P; Jeanguillaume C; Mellière D; Berthelot JM; Menoyo-Calonge V; Chiappini-Briffa D; Janin A; Galle P
    Lancet; 1999 Jun; 353(9171):2200-4. PubMed ID: 10392985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism.
    Adalet I; Hawkins T; Clark F; Wilkinson R
    Eur J Nucl Med; 1994 Jun; 21(6):509-13. PubMed ID: 8082665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
    Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
    Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid scintigraphy with iodine-123 and 99mTc-sestamibi: imaging findings.
    Burke GJ; Wei JP; Binet EF
    AJR Am J Roentgenol; 1993 Dec; 161(6):1265-8. PubMed ID: 8249740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection and localization of parathyroid adenomas and hyperplasias in patients with hyperparathyroidism using thallium-201/technetium-99m parathyroid subtraction scintigraphy].
    Kanegae K; Itoh K; Kato C; Nagao K; Nakada K; Fujimori K; Furudate M
    Kaku Igaku; 1994 May; 31(5):441-9. PubMed ID: 8028216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of thoracic hemorrhage due to ectopic parathyroid hyperplasia with chronic renal failure.
    Akimoto T; Saito O; Muto S; Hasegawa T; Nokubi M; Numata A; Ando Y; Sohara Y; Saito K; Kusano E
    Am J Kidney Dis; 2005 Jun; 45(6):e109-14. PubMed ID: 15957122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.
    O'Doherty MJ; Kettle AG; Wells P; Collins RE; Coakley AJ
    J Nucl Med; 1992 Mar; 33(3):313-8. PubMed ID: 1531500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Utility of 99m Tc MIBI gammagraphy before parathyroidectomy in patients with secondary hyperparathyroidism].
    Martín F; Sarró F; Verdú J; Martínez A
    Nefrologia; 2001; 21(2):221-2. PubMed ID: 11464660
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
    Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
    Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of a parathyroid adenoma with Tc-99m MIBI in a case with iodine saturation and impaired thallium uptake.
    Osmanagaoglu K; Schelstraete K; Lippens M; Obrie E; De Feyter I
    Clin Nucl Med; 1993 Mar; 18(3):214-6. PubMed ID: 8384942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-pertechnetate uptake by intrathyroidal parathyroid adenoma.
    Leslie WD; Riese KT; Guzman R; Dupont JO; Peterdy AE
    J Nucl Med; 1996 May; 37(5):861-2. PubMed ID: 8965164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m-methoxyisobutylisonitrile in localization of ectopic parathyroid adenoma.
    Bernà L; Caixàs A; Piera J; Gómez G; Matías-Guiu X; Estorch M; Puig M; Carrió I
    J Nucl Med; 1996 Apr; 37(4):631-3. PubMed ID: 8691254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of an ectopic parathyroid adenoma by double-phase technetium-99m-sestamibi scintigraphy.
    Caravalho J; Balingit AG; Rivera-Rodríguez JE; Shriver CD; Koops MK
    J Nucl Med; 1995 Oct; 36(10):1840-2. PubMed ID: 7562052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.